N2OFF receives Nasdaq bid price deficiency notice; 180-day cure period

Nexentis Technologies Inc.

Nasdaq notified N2OFF that its stock (NITO) closed below $1.00 for 30 consecutive business days, violating Listing Rule 5450(a)(1).
Compliance period runs until January 6, 2025; if bid price closes at $1.00 or more for 10 consecutive days, deficiency cured.
If not cured, N2OFF may get an additional 180-day period if it meets market value of publicly held shares and intends a reverse stock split.
Failure to regain compliance within allotted periods may result in delisting from Nasdaq Capital Market.
Continued listing not immediately affected; stock remains traded under NITO symbol.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.